|
J Biol Chem, Vol. 275, Issue 20, 14910-14915, May 19, 2000
Dissection of Protein Linkage between Keratins and Pinin, a
Protein with Dual Location at Desmosome-Intermediate Filament
Complex and in the Nucleus*
Jia
Shi and
Stephen P.
Sugrue
From the Department of Anatomy and Cell Biology, University of
Florida College of Medicine, Gainesville, Florida 32610-0235
 |
ABSTRACT |
Pinin is a cell adhesion-associated and nuclear
protein that has been shown to localize in the vicinity of intermediate
filament (IF) convergence upon the cytoplasmic face of the desmosomal
plaque as well as in the nucleus. The localization of pinin to the
desmosomes has been correlated with the reinforcement of intercellular
adhesion and increased IF organization. In this study, keratins 18, 8, and 19 were identified to interact with the amino end domain of pinin
in a two-hybrid screening. Further truncation analyses indicated that
the 2B domain of keratin contains the sequence responsible for
interacting with pinin. The amino end of pinin (residues 1-98) is
sufficient to bind to keratin. Point mutation analyses revealed two
essential residues within the pinin fragment 1-98, leucine 8 and
leucine 19, for the interaction with keratin. Finally, in vitro protein overlay binding assays confirmed the direct
interaction of the amino end domain of pinin with keratins, while pinin
mutant L8P GST fusion protein failed to bind to keratins in the overlay assay. Coupled with our previous morphological observations and transfection studies, these data suggest that pinin may play a role in
epithelial cell adhesion and the IF complex through a direct
interaction with the keratin filaments.
 |
INTRODUCTION |
Pinin was first identified to be a protein associated with the
desmosome, which was recruited to the preformed desmosomes of the
epithelia but absent at nascent desmosomes (1). Immunofluorescence and
immuno-EM studies have shown pinin decorating keratin filaments near
the cytoplasmic face of the desmosomal plaque in the vicinity of
keratin filament convergence upon the desmosome. Our previous studies
have revealed a correlation between the placement of pinin at the
desmosome and an increase in the organization/stabilization of
desmosome-IF1 complex (1, 2).
Presumably, one of the functions of pinin is related to the
desmosome-IF complex.
The expression level of pinin has been correlated with the overall
epithelial phenotype. HEK-293 cells, when transfected with pinin
full-length cDNA, exhibited a striking phenotype change from a
fibroblast-like spindle shape to cells with extensive cell-cell contact
growing in culture as islands (2). Intriguingly, EM analysis of these
transfected cells revealed that the array of epithelial cell junctions
was enhanced. In addition, carcinoma-derived cells, when transfected
with pinin cDNA, exhibited inhibition of anchorage-independent
growth in soft agar. Furthermore, pinin's gene locus and dysregulation
of pinin expression in primary tumor tissues suggest that pinin may
function as a tumor suppressor in certain types of cancer (3, 4).
Pinin has also been localized in the nucleus in various tissues as well
as in cultured cell lines (5-7). Brandner et al. (6) has
proposed an involvement of pinin in spliceosomal function. The dual
location of pinin may be indicative of the involvement of pinin in
multiple cellular activities, both at the desmosome and in the nucleus;
however, it is not yet clear whether or not the function of pinin in
cell-cell adhesion is coordinated with its function in the nucleus. As
a step toward understanding the functions of pinin, we sought to
identify proteins that interact with pinin. In this study, we focus on
the ability of pinin to bind keratin.
Keratin filaments are anchored to the lateral plasma membrane at
desmosomes. These intercellular junctions reinforce epithelial adhesion
as well as integrate the IF network across the entire epithelium.
Numerous structure-function studies of desmosomal proteins have
revealed details pertaining to the molecular organization of
desmosome-IF complex. The relationships among the desmosomal components
have been extensively reviewed elsewhere (8-11). The constitutive
components of the desmosome include desmosomal cadherins (desmogleins
and desmocollins) and plaque proteins, plakoglobin, desmoplakin, and
plakophilin. Among these proteins, desmoplakin (12, 13) and plakophilin
(11, 14) have been shown to bind directly to keratins. In addition,
other peripherally associated desmosome proteins such as plectin (15,
16), envoplakin/periplakin (17, 18), and pinin (1) are also thought to
interact, directly or indirectly, with keratin. Significant questions
pertaining to the molecular associations and specific roles of these
accessory proteins of the desmosome remain.
To identify potential protein-protein interactions of pinin, a
two-hybrid screening was performed with either the amino portion or the
carboxyl portion of pinin as bait. In this study, we presented a
detailed analysis on the binding of the amino end domain of pinin to
one group of the identified proteins, the keratins. Keratin 18 (K18),
keratin 8 (K8), and keratin 19 (K19) were shown to interact with the
amino portion of pinin in the two-hybrid screen. Further truncation
analyses defined the specific domain of keratin that mediates the
interaction. In addition, the specific domain of pinin molecule
sufficient for the interaction was characterized, and through
site-directed mutagenesis, the essential residues within this
particular domain were investigated. In vitro blot overlay
assays were performed to confirm the interaction between the amino end
domain of pinin and the keratins. Overall, our data strongly suggest
that pinin is capable of binding directly to the intermediate filament
proteins, specifically the keratins. These data provide important
information on eventual understanding of mechanism by which pinin may
affect the assembly/stabilization of epithelial cell adhesion.
 |
MATERIALS AND METHODS |
Yeast Strain and Media--
The Saccharomyces
cerevisiae strain PJ69-4A (MATa trp1-901 leu2-3, 112 ura3-52 his3-200 gal4 gal80D LYS2::GAL1-HIS3 GAL2-ADE2 met::GAL7-lacZ) (19) was used in all the two-hybrid
assays. The yeast was grown on synthetic medium (SD) with appropriate amino acid-omissions for plasmid selection. Tryptophan and leucine were
selective markers for the co-transformed bait and prey plasmids. Histidine 3, adenine 2, and lacZ are reporter genes for
interaction between GAL4-BD and GAL4-AD. In " HIS" medium,
histidine was omitted as well as tryptophan and leucine, while in
" Ade" medium, adenine was omitted as well as tryptophan and
leucine. In addition, 1 mM 3-aminotriazole was added in all
of the media to inhibit the autoactivation of the histidine 3 reporter gene.
Bait Construct and Two-hybrid Screening--
The DNA fragment
encoding for pinin residues 1-480 was obtained by PCR and cloned
in-frame into the GAL4 DNA binding domain (GAL4BD; bait) vector pAS2-1
(CLONTECH, Matchmaker II system). The GAL4BD-pinin
vector was co-transformed with a CLONTECH
Matchmaker cDNA library into the yeast strain PJ69-4A using the
yeast transformation method of Gietz et al. (20). The
library consisted of human fetal kidney cDNA fused to the
activation domain of GAL4 (GAL4AD, prey) in the pGAD 10 vector
(CLONTECH).
Approximately 106 transformants were screened. They were
initially subjected to HIS selection; subsequently, the colonies of
surviving yeast were replicated to Ade plates. Positive colonies from
Ade selection were subjected to liquid culture ONPG -galactosidase assays according to the manufacturer's procedure
(CLONTECH). The interaction between p53 and SV40
large T-antigen was used as a positive control in -galactosidase
assays according to the manufacturer's procedures. The base-line level
of -galactosidase activity was determined from control yeast
co-transformed with GAL4-BD-pinin (residues 1-480) and GAL4-AD. Each
reported value of -galactosidase units represented an average enzyme
activity determined from three independent colonies. The "prey"
plasmids were recovered from triple positive (HIS, Ade, and LacZ)
clones and co-transformed with the control heterologous bait:
GAL4BD-p53, GAL4BD-pinin C' (residues 470-717), or GAL4BD alone. In
addition, the "prey" plasmid was also transformed by itself into
the yeast host to rule out potential false-positives. Clones growing on
HIS, Ade, exhibiting -galactosidase activity and exhibiting no
interaction with control baits, were subjected to sequencing.
To examine the ability of truncations of pinin to interact with
keratin, the GAL4BD vectors containing the individual pinin truncations
or point mutation constructs were co-transformed with the pGAD10 vector
containing keratin 18 into PJ69-4A yeast. To examine the ability of
truncations of keratin 18 to interact with the amino end of pinin, the
original bait was co-transformed with individual truncations of keratin
18, fused to the activation domain of GAL4 in the pGAD10.
Co-transformants were assayed for growth on HIS and Ade and
-galactosidase activity.
Generation of Pinin/Keratin Truncations and Pinin Point
Mutations--
Truncations of pinin and truncations of keratin 18 were
generated by PCR using the primer sets listed in Tables
I and II. PCR products of human pinin were fused in frame to the GAL4BD in the
vector pAS2-1 at NdeI/SalI sites. PCR products
of human keratin 18 were fused in frame to the GAL4AD in the vector
pGAD10 at XhoI/EcoRI sites. Point mutations of
the pinin amino end 1-480, fused in frame to GAL4BD in the pAS2-1
vector, were generated using the Quick Change site-directed mutagenesis
kit (Stratagene, La Jolla, CA) with the primer sets listed in Table
III. As above, co-transformants were
assayed for growth on HIS and Ade and -galactosidase
activity.
Expression of Pinin Fusion Protein in Escherichia coli and
Generation of the Polyclonal Antibody against the Pinin GST-Fusion
Protein--
Pinin residues 1-165 were obtained by PCR with primers
STS 65 (5'-CCG AAT TCC CGC TTC AGA GAG AAG ATG-3') and STS 61 (5'-CGC TCG AGG GCC TTT CAG TAG CAA CAG-3'). This PCR fragment was cloned in
frame to vector pGEX-4T-3 (Amersham Pharmacia Biotech) at
XhoI/EcoRI sites. The glutathione
S-transferase (GST) fusion protein GST-cp-(1-165) was
expressed in E. coli strain BL21 (Novagen) and purified with glutathione-Sepharose 4B (Amersham Pharmacia Biotech) according to the
manufacturer's instructions. Similarly, a mutant GST fusion protein of
the residues 1-165, GST-cp-(1-165) L8P, with a substitution of
leucine 8 by a proline, was generated with the Quick Change site-directed mutagenesis kit (Stratagene, La Jolla, CA), expressed and
purified as described above.
The pinin DNA encoding for 5'-end residues 1-165 was also cloned into
pET 28(+)b (pET system; Novagen) and expressed as a T7-tagged and
His6 fusion protein in E. coli strain BL21
(Novagen). The fusion protein was affinity-purified using the charged
HIS·Bind metal chelation resin (Ni2+ beads) following the
instructions of the manufacturer (Novagen, pET System Manual).
A rabbit polyclonal antibody (UF215) was generated using the
GST-cp-(1-165) as antigen (Cocalico Biologicals, Inc.). The specific immunoactivity of UF 215 to pinin's amino domain was verified by
Western blot on pET System expressed His6 fusion protein
described above (data not shown).
Purification of Keratin Filament Protein from Madin-Darby Canine
Kidney Cells--
Madin-Darby canine kidney cells were grown to
confluence in Dulbecco's modified Eagle's medium (Life Technologies,
Inc.), supplemented with 10% fetal calf serum (Life Technologies,
Inc.), 2 mM glutamine and 200 units/ml each of penicillin
and streptomycin. Keratin proteins were then prepared from these cells
according to a procedure described elsewhere (21, 22) with slight
modifications. Cells were lysed in PBS (containing 1% Triton X-100,
0.6 M KCl, 1 mM MgCl2, 5 mM EDTA, 5 mM EGTA, and the following protease
inhibitors: 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 1 mg/ml leupeptin, 1 mg/ml pepstatin A,
1 mg/ml aprotinin (Sigma)). The extract was treated with DNase (0.5 µg/ml) at 37 °C for 20 min and then centrifuged at 2000 × g at 4 °C for 10 min to pellet the IF-enriched
cytoskeleton. The IF-enriched cytoskeletal preparation was first
extracted with PBS containing 5 mM EDTA, 0.5 mM
phenylmethylsulfonyl fluoride, and 1 mM dithiothreitol. The
pellet was then sequentially extracted with low salt buffer (60 mM KCl, 1 mM EDTA, 1 mM cysteine, 10 mM ATP, 40 mM imidazole, pH 7.1), high salt
buffer (0.6 M KCl, 1 mM EDTA, 2 mM
ATP, 1 mM cysteine, 40 mM imidazole), and low salt buffer again. This KCl-extracted pellet was dissolved in 8 M urea in 10 mM Tris·HCl buffer supplied with
protease inhibitors and subjected to ultracentrifugation at
125,000 × g for 1 h at 4 °C. The supernatant
was dialyzed into 10 mM Tris·HCl and frozen at
80 °C.
In Vitro Blot Overlay Binding Assays--
In vitro
overlay protein binding assays were performed as described elsewhere
with slight modification (11). 2 µg of purified keratin, bovine serum
albumin, pinin amino end fragment 1-165, and mutant pinin 1-165 L8P
were separated on a 10% SDS-PAGE. The proteins were then transferred
to nitrocellulose membranes. Membranes were blocked by incubation in
reaction buffer (10 mM Tris·HCl, 150 mM NaCl,
1 mM MgCl2, pH 7.4) with the addition of 0.1%
(v/v) Tween 20 and 5% (w/v) nonfat milk powder at 4 °C overnight.
Blots were incubated 4 h at room temperature with the bacterially
expressed pinin amino domain, either wild type GST-cp-(1-165) or
mutant GST-cp-(1-165) L8P (3 µg/ml in the reaction buffer with the
addition of protease inhibitor mixture (Boehringer Mannheim) and 0.1%
Tween 20, 1% bovine serum albumin, and 0.5% Triton X-100). After
incubations, the blots were washed thoroughly with several fresh
changes of the reaction buffer and subjected to routine Western
blotting with anti-pinin antiserum and ECL (Amersham Pharmacia
Biotech). Specifically, UF215 diluted 1:1000 in TBST (10 mM
Tris·HCl, 150 mM NaCl, 1 mM
MgCl2, 0.1% Tween 20, pH 7.4) was used as the primary antibody. Blots were incubated in 5% normal goat serum in TBS prior to
secondary antibody (goat anti-rabbit IgG, Amersham Pharmacia Biotech;
1:10,000) incubation. As a control for the protein overlays, GST was
used instead of wild type pinin fusion protein and subsequently probed
with anti-GST antibody (Amersham Pharmacia Biotech) via Western blot.
 |
RESULTS |
K18, K8, and K19 Were Identified in a Yeast Two-hybrid Screening by
the Amino Portion Fragment of Pinin--
In an effort to identify
proteins that bind to the amino-terminal domain of pinin, a yeast
two-hybrid screening on a human fetal kidney cDNA library
(CLONTECH) using pinin (residues 1-480) as bait
was performed. Of the approximately 106 transformants
screened, 21 independent cDNA clones were isolated. The recovered
prey plasmids were verified by co-transforming each of the plasmids
with either GAL4BD-pinin N' (residues 1-480) or control heterologous
baits, including GAL4BD-p53, GAL4BD-pinin C' (residues 470-717), and
GAL4BD. All of the negative controls displayed no growth on the
selective media, indicative that the interaction of the prey plasmid
with the specific pinin bait resulted in the activation of the reporter
gene requisite for growth. The most prevalent protein that exhibited
binding to the amino end of pinin was keratin. Five of the identified
clones encoded full-length keratin 18 (residues 1-430), one encoded
the rod domain of keratin 8 (residues 90-387), and another encoded the
rod and the tail domain of keratin 19 (residues 69-400) (Fig.
1).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 1.
Two-hybrid analyses demonstrated that the
coil 2 within the rod domain of K18/K8/K19 contained sufficient
sequence to bind to the amino-terminal domain of pinin
hp-(1-480). Human pinin (residues 1-480) fused to GAL4-BD and
one of the keratin constructs fused to GAL4-AD were cotransformed into
the yeast host strain PJ69-4A. Transformants were subjected to HIS,
Ade, and -galactosidase selection assays. A, yeast
containing pinin N' bait hp-(1-480) and one of the coil 2 constructs,
K18-(234-391), K8-(260-388), and K19-(244-390), exhibited growth on
Ade selective medium SD/ Trp, Leu, Ade, while yeast containing
hp-(1-480) and one of the coil 1 constructs, K18-(69-240),
K8-(91-235), or K19-(81-229), exhibited no growth. B,
-galactosidase activity ( -gal units) obtained from
quantitative -galactosidase assay of each transformant confirmed the
results from Ade selection assay, that the coil 2 domain and
hp-(1-480) interacted with each other to activate the lacZ
gene, while no interaction occurred between the coil 1 domain of
K18/K8/K19 and hp-(1-480).
|
|
The 2B Domain of Keratin Contains the Binding Site for
Pinin--
K18, K8, and K19 are three keratins expressed in the simple
epithelial cells. These keratins share common structural properties. Each possesses an amino end nonhelical head domain, a central coiled-coil -helical domain, and a nonhelical tail domain in various
lengths (23, 24). Because pinin (residues 1-480) bound equally well to
each of these keratin clones and the common domain shared by all of the
clones was the rod domain, we surmised that the rod domain might
contain the sufficient sequence for the interaction with pinin. To
further map the binding site within keratin, truncation constructs
coding either coil 1 or coil 2 of K18/K8/K19 were generated and
examined for their ability to bind pinin in a two-hybrid assay (Fig.
1). While constructs containing the coil 1 domain of K18 (residues
69-240), K19 (residues 81-235), and K8 (residues 91-235) exhibited
no significant binding to pinin (residues 1-480), the coil
2-containing constructs of K18 (residues 234-391), K19 (residues 244-390), and K8 (residues 260-381) all exhibited interaction with
pinin. It was, however, noticed that the coil 2-pinin interactions were
approximately 10-fold weaker than the interaction of the intact keratin
rod domain as indicated by the -galactosidase assay. While reporter
gene activity, such as -galactosidase, does not correspond linearly
with the strength of interaction, these assays can be useful in
estimating relative strength of interactions between similar molecules
or domains. The data suggest that either some sequence outside the coil
2 domain may contribute to the interaction or that the longer
constructs may present the binding domain of keratin in a more
advantageous conformation for pinin binding.
The carboxyl terminus of the 2B domain within coil 2 contains a highly
conserved consensus motif, suggested to be significant for
assembly/stabilization of the intermediate filaments in cells (25-28).
K18 (residues 69-276), which excluded the entire 2B domain, failed to
interact with pinin (residues 1-480). However, K18 (residues 69-372),
which contained the majority of the rod domain but not the consensus
motif, retained the ability to bind to pinin (residues 1-480) (Fig.
2). Considering this, together with the
results shown in Fig. 1, we conclude that the 2B domain of keratin
contained the binding site for pinin.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 2.
Two-hybrid analyses defined the 2B domain of
keratin 18 interacting with pinin amino portion 1-480. Either the
2B consensus motif deletion construct K18(69-372) or the 2B domain
deletion construct K18(69-276) was cotransformed into yeast PJ69-4A
with hp-(1-480). The cotransformants were selected on HIS, Ade
medium and subjected to -galactosidase ( -gal) assay.
A, yeast containing K18 (69-372), as well as yeast
containing full-length K18 exhibited growth on SD/ Trp, Leu, Ade
medium, while the yeast containing K18 (69-276) exhibited no growth.
B, -galactosidase assays indicated that K18-(69-372) is
able to bind to hp-(1-480), while K18-(69-276) exhibited no binding
to hp-(1-480).
|
|
Pinin Residues 1-98 Are Sufficient for Interacting with
Keratins--
The amino end of pinin (residues 1-480) contains a
short domain with heptad repeats, a few glycine loops (29), and a
rather extensive glutamate-rich -helix domain (2). To more precisely map the domain of pinin that is sufficient for the interaction with
keratin, five pinin truncation constructs were generated for two-hybrid
analyses (Fig. 3). Constructs lacking the
amino terminus of pinin (residues 85-480, 250-480, and 85-252)
exhibited no significant interaction with keratin, while constructs
(residues 1-252 and residues 1-98) containing amino end heptad
repeats and glycine loops exhibited binding to keratin.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 3.
Two-hybrid analyses mapped the site in pinin
for interacting with keratin 18. Human pinin constructs were
cotransformed with K18 into yeast PJ69-4A. As indicated by growth on
selective medium SD/ Trp, Leu, Ade (A) and
-galactosidase ( -gal) activity (B), pinin
fragment hp-(1-98), which contains the predicted heptad repeat and
glycine loop domains, is sufficient for the interaction of pinin with
keratin 18.
|
|
Leucine 8 and Leucine 19 within Pinin Are Essential for Binding to
Keratin--
To further define the specific region within the amino
end of pinin that is essential for binding to keratin, site-directed mutagenesis was employed. Leucine residues at positions 8, 19, and 29, which were predicted to locate at either the "a" or "d" position of the heptad repeats within pinin (30-32), were substituted with proline (N' L8P, N' L19P, and N' L29P). Interestingly, both N' L8P
and N' L19P resulted in no growth at all on Ade medium (Fig.
4A) and a base line level of
-galactosidase activity (Fig. 4B), indicating the
interaction between pinin and K18 was abolished with a single mutation.
On the contrary, N' L29P retained the ability to grow on Ade medium,
but the -galactosidase activity was somewhat reduced. One glycine
within the predicted first glycine loop of pinin was replaced by
glutamate (N' G53Q). This substitution, similar to N' L29P, did not
affect the growth of transformed yeast under selection conditions, but
it resulted in a somewhat weaker interaction, as indicated by reduction
in -galactosidase activity. Charged residues have been speculated to
stabilize coiled-coil conformations. However, changes of arginine 6 and
lysine 28 to aspartate and glutamate, respectively (N' R6D, N' K28E),
resulted in only a slight dampening in the -galactosidase activity
(Fig. 4). In summary, leucine 8 and 19 were shown to be essential for pinin-keratin interaction, whereas leucine 29, glycine 53, arginine 6, and lysine 28 were not essential but may somehow be involved in the
optimal pinin-keratin interaction. Whether or not multiple (additive)
substitutions of the residues would result in a more obvious effect on
the pinin-keratin interaction is currently under investigation.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Two-hybrid analyses identified the essential
residues within hp-(1-98) for the interaction between pinin and
keratin 18. GAL4-AD-K18 and each of the GAL4-BD-hp N' mutant
constructs were cotransformed into yeast. A, N'L8P and
N'L19P resulted in no growth on Ade medium, while N'L29P, N'G53Q,
N'R6D, and N' K28E retained the ability to grow. B,
-galactosidase ( -gal) assay results indicated no
binding between N' L8P/N' L19P and hp-(1-480), while N' L29P, N' G53Q,
N' R6D, and N' K28E remained to interact with hp-(1-480).
|
|
In Vitro Overlay Binding Assays Verified the Direct Interaction
between Pinin Amino End Domain and Keratins--
Keratin, purified
from Madin-Darby canine kidney cells and bacterially expressed pinin
fragments, both wild type GST-cp-(1-165) and mutant GST-cp-(1-165)
L8P, were utilized in the blot overlay binding analyses. Blots
containing keratin preparations were overlaid with either wild type
pinin GST fusion protein GST-cp-(1-165) or mutated pinin GST fusion
protein GST-cp-(1-165) L8P and subsequently reacted with UF 215 (Fig.
5B). Only the wild type pinin
construct exhibited binding to keratin, as visualized by its
immunoreactivity with anti-pinin antiserum UF215. The fact that the
mutation L8P, which eliminated pinin-keratin binding in the two-hybrid
assay, showed no binding in the overlay assays provides strong support for the specificity of the in vitro binding assay and
confirmed the observations from the two-hybrid assays. We conclude that the amino end domain of pinin is capable of directly binding to keratin.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 5.
In vitro overlay binding assays
confirmed the interaction between pinin amino end domain and
keratins. A, SDS-PAGE stained with Coomassie Blue
demonstrated the proteins utilized in the overlay binding assay.
Lane 1, purified Madin-Darby canine kidney
keratins; lane 2, bovine serum albumin;
lane 3, pinin GST fusion protein GST-cp-(1-165);
lane 4, mutant pinin GST fusion protein
GST-cp-(1-165) L8P. Keratins were confirmed by Western blot probed
with anti-keratin antibody (A, lane
1). Both wild type and mutant pinin GST fusion proteins were
recognized by anti-pinin antibody UF 215 (A,
lanes 3 and 4). B, purified
keratins (lane 1) and bovine serum albumin
(lane 2) were overlaid with either wild type
GST-cp-(1-165) (WT O/L) or mutant GST-cp-(1-165) L8P
(L8P O/P). Binding of any of these proteins to keratins was
detected by Western blot using anti-pinin antibody UF215. Wild type
GST-cp-(1-165) did bind to keratins and was recognized by UF 215, while mutant GST-cp-(1-165) L8P did not bind to keratins.
|
|
 |
DISCUSSION |
In this study, we present data demonstrating the direct
interaction of the amino end domain of pinin with the 2B domain of keratin from simple epithelial cells. These data are not only consistent with our previous morphological observations but provide biochemical support of pinin-IF association.
There are four distinct coiled-coil stretches, 1A, 1B, 2A, and 2B in
the central rod domain of a keratin molecule. Our data indicate that
pinin binds to the sequence within the 2B domain of keratin. Coil 1 of
keratin exhibited no binding to pinin, strongly supporting the
conclusion that the interaction between the 2B domain of keratin and
pinin amino-terminal domain is indeed specific and not due to
nonspecific interaction with coiled-coil-containing proteins. Direct
binding to the rod 2B domain of keratin 18 has been reported for BPAG
2, a hemidesmosome-associated protein (33). While desmoplakin has been
shown to bind to the head domain of epidermal keratins, such as keratin
1/keratin 10 and keratin 5/keratin 14 (11), it has also been shown to
be capable of binding to the rod domain of simple epithelial keratin
K8/K18 heterodimer (13).
The truncation analyses suggested the amino end of pinin (residues
1-98) contained the sequence responsible for binding to keratin.
Although short coiled-coils composed of four to five heptad repeats
have been reported (31), it is not clear whether the four and a half
heptad repeats at the amino end of pinin are actually sufficient to
form a coiled-coil structure in vivo. The amino end of pinin
does not contain a "trigger sequence" (34), so it may not
participate in the formation of a coiled-coil. However, data derived
from point mutation analyses of the amino-terminal domain of pinin
suggest the sequence within the heptad repeats is indeed essential for
the interaction with keratin. N' L8P and N' L19P completely abolished
the binding of pinin to K18, whereas N' L29P did not, suggesting that
the heptad repeats located nearer the amino end of pinin may play a
more significant role in pinin-keratin interaction.
We have suggested that pinin may function as a tumor suppressor based
on chromosomal location of pinin and tumor biological analyses (4). It
has been shown that the expression of pinin was absent or greatly
reduced in certain carcinomas, including renal cell carcinoma and
transitional cell carcinoma. On the other hand, pinin expression was
up-regulated in a subset of melanoma tissues (3) and a subset of renal
cell carcinoma (4). Decreased expression of pinin was correlated with
loss of epithelial cell-cell adhesion, while increasing pinin
expression by transfection of pinin cDNA was shown to enhance
cell-cell adhesion (4, 35). Interestingly, K18 and K8 have long been
considered as cytological markers for carcinomas due to their
persistent expression in tumor cells derived from simple epithelia and
their aberrant expression in malignant progression of nonepithelial
cells (36-39). In addition, several studies suggested that K18/K8
filaments have a role in the tumorigenicity. For example, in
K8-deficient mice, adult animals developed pronounced colorectal
hyperplasia (40), and the expression of K8 and K18 in human
melanoma cell lines resulted in increased invasive and metastatic
properties of the cells (37, 41). It is tempting to speculate that the
tumor suppressor function of pinin is related to the interaction of
pinin with keratin.
This study did not address the important issue regarding the
relationship between the desmosome and pinin. Our initial two-hybrid screens identified other, as of yet uncharacterized, proteins interacting with pinin N' bait
1-480.2 One of these
clones coded for a protein containing motifs highly homologous to
periplakin (18), a desmosome-IF-associated protein forming cornified
envelope in the stratified epithelial cells. The possibility of
pinin connecting to desmosome through this periplakin-like protein is
currently being addressed.
In summary, we have demonstrated that pinin can bind to keratin 18, keratin 8, and keratin 19. The 2B domain of keratin contains the
sequence mediating the interaction with pinin, and the amino end
(residues 1-98) of pinin was sufficient to bind keratin.
Identification of specific binding sites within pinin for keratin and
for other proteins will be an integral step for future studies. We
believe that investigation of the function(s) of pinin in cell adhesion and IF organization will greatly contribute to our current knowledge of
epithelial cell-cell adhesion.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant EY07883.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Anatomy and
Cell Biology, University of Florida College of Medicine, 1600 S.W.
Archer Rd., Gainesville, FL 32610-0235. Tel.: 352-392-3569; Fax:
352-392-3305; E-mail: sugrue@anatomy.med.ufl.edu.
2
J. Shi and S. P. Sugrue, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
IF, intermediate
filament;
K8, K18, and K19, keratin 8, 18, and 19, respectively;
PCR, polymerase chain reaction;
AD, activation domain;
BD, binding
domain.
 |
REFERENCES |
| 1.
|
Ouyang, P.,
and Sugrue, S. P.
(1992)
J. Cell Biol.
118,
1477-1488[Abstract/Free Full Text]
|
| 2.
|
Ouyang, P.,
and Sugrue, S. P.
(1996)
J. Cell Biol.
135,
1027-1042[Abstract/Free Full Text]
|
| 3.
|
Degen, W. G.,
Agterbos, M. A.,
Muyrers, J. P.,
Bloemers, H. P.,
and Swart, G. W.
(1999)
Biochim. Biophys. Acta
1444,
384-394[Medline]
[Order article via Infotrieve]
|
| 4.
|
Shi, Y.,
and Sugrue, S. P.
(2000)
Oncogene
19,
289-297[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Brandner, J. M.,
Reidenbach, S.,
and Franke, W. W.
(1997)
Differentiation
62,
119-127[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Brandner, J. M.,
Reidenbach, S.,
Kuhn, C.,
and Franke, W. W.
(1998)
Eur J. Cell Biol.
75,
295-308[Medline]
[Order article via Infotrieve]
|
| 7.
|
Ouyang, P.
(1999)
Biochem. Biophys. Res. Commun.
263,
192-200[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Kowalczyk, A. P.,
Bornslaeger, E. A.,
Norvell, S. M.,
Palka, H. L.,
and Green, K. J.
(1999)
Int. Rev. Cytol.
185,
237-302[Medline]
[Order article via Infotrieve]
|
| 9.
|
Troyanovsky, S. M.,
and Leube, R. E.
(1998)
Subcell. Biochem.
31,
263-289[Medline]
[Order article via Infotrieve]
|
| 10.
|
Fuchs, E.,
Yang, Y.,
Dowling, J.,
Kouklis, P.,
Smith, E.,
Guo, L.,
and Yu, Q. C.
(1997)
Soc. Gen. Physiol. Ser.
52,
141-148[Medline]
[Order article via Infotrieve]
|
| 11.
|
Smith, E. A.,
and Fuchs, E.
(1998)
J. Cell Biol.
141,
1229-1241[Abstract/Free Full Text]
|
| 12.
|
Kouklis, P. D.,
Hutton, E.,
and Fuchs, E.
(1994)
J. Cell Biol.
127,
1049-1060[Abstract/Free Full Text]
|
| 13.
|
Meng, J. J.,
Bornslaeger, E. A.,
Green, K. J.,
Steinert, P. M.,
and Ip, W.
(1997)
J. Biol. Chem.
272,
21495-21503[Abstract/Free Full Text]
|
| 14.
|
Hatzfeld, M.,
Kristjansson, G. I.,
Plessmann, U.,
and Weber, K.
(1994)
J. Cell Sci.
107,
2259-2270[Abstract]
|
| 15.
|
Foisner, R.,
Leichtfried, F. E.,
Herrmann, H.,
Small, J. V.,
Lawson, D.,
and Wiche, G.
(1988)
J. Cell Biol.
106,
723-733[Abstract/Free Full Text]
|
| 16.
|
Wiche, G.,
Gromov, D.,
Donovan, A.,
Castanon, M. J.,
and Fuchs, E.
(1993)
J. Cell Biol.
121,
607-619[Abstract/Free Full Text]
|
| 17.
|
Ruhrberg, C.,
Hajibagheri, M. A.,
Simon, M.,
Dooley, T. P.,
and Watt, F. M.
(1996)
J. Cell Biol.
134,
715-729[Abstract/Free Full Text]
|
| 18.
|
Ruhrberg, C.,
Hajibagheri, M. A.,
Parry, D. A.,
and Watt, F. M.
(1997)
J. Cell Biol.
139,
1835-1849[Abstract/Free Full Text]
|
| 19.
|
James, P.,
Halladay, J.,
and Craig, E. A.
(1996)
Genetics
144,
1425-1436[Abstract]
|
| 20.
|
Gietz, R. D.,
Triggs-Raine, B.,
Robbins, A.,
Graham, K. C.,
and Woods, R. A.
(1997)
Mol. Cell. Biochem.
172,
67-79[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Zackroff, R. V.,
Goldman, A. E.,
Jones, J. C.,
Steinert, P. M.,
and Goldman, R. D.
(1984)
J. Cell Biol.
98,
1231-1237[Abstract/Free Full Text]
|
| 22.
|
Aynardi, M. W.,
Steinert, P. M.,
and Goldman, R. D.
(1984)
J. Cell Biol.
98,
1407-1421[Abstract/Free Full Text]
|
| 23.
|
Steinert, P. M.,
and Roop, D. R.
(1988)
Annu. Rev. Biochem.
57,
593-625[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Fuchs, E.,
and Weber, K.
(1994)
Annu. Rev. Biochem.
63,
345-382[Medline]
[Order article via Infotrieve]
|
| 25.
|
Albers, K.,
and Fuchs, E.
(1987)
J. Cell Biol.
105,
791-806[Abstract/Free Full Text]
|
| 26.
|
Hatzfeld, M.,
and Weber, K.
(1992)
J. Cell Biol.
116,
157-166[Abstract/Free Full Text]
|
| 27.
|
Albers, K.,
and Fuchs, E.
(1989)
J. Cell Biol.
108,
1477-1493[Abstract/Free Full Text]
|
| 28.
|
Kouklis, P. D.,
Traub, P.,
and Georgatos, S. D.
(1992)
J. Cell Sci.
102,
31-41[Abstract/Free Full Text]
|
| 29.
|
Steinert, P. M.,
Mack, J. W.,
Korge, B. P.,
Gan, S. Q.,
Haynes, S. R.,
and Steven, A. C.
(1991)
Int. J. Biol. Macromol.
13,
130-139[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Lupas, A.
(1996)
Methods Enzymol.
266,
513-525[Medline]
[Order article via Infotrieve]
|
| 31.
|
Lupas, A.
(1997)
Curr. Opin. Struct. Biol.
7,
388-393[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Berger, B.,
Wilson, D. B.,
Wolf, E.,
Tonchev, T.,
Milla, M.,
and Kim, P. S.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8259-8263[Abstract/Free Full Text]
|
| 33.
|
Aho, S.,
and Uitto, J.
(1999)
J. Cell. Biochem.
72,
356-367[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Kammerer, R. A.,
Schulthess, T.,
Landwehr, R.,
Lustig, A.,
Engel, J.,
Aebi, U.,
and Steinmetz, M. O.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
13419-13424[Abstract/Free Full Text]
|
| 35.
|
Shi, Y.,
Tabesh, M.,
and Sugrue, S. P.
(2000)
Ivest. Ophthalmol. Vis. Sci.
41,
1337-1345[Abstract/Free Full Text]
|
| 36.
|
Moll, R.,
Franke, W. W.,
Schiller, D. L.,
Geiger, B.,
and Krepler, R.
(1982)
Cell
31,
11-24[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Hendrix, M. J.,
Seftor, E. A.,
Chu, Y. W.,
Seftor, R. E.,
Nagle, R. B.,
McDaniel, K. M.,
Leong, S. P.,
Yohem, K. H.,
Leibovitz, A. M.,
Meyskens, F. L., Jr.,
Conaway, D. H.,
Welch, D. R.,
Liotta, L. A.,
and Stetler-Steveson, W.
(1992)
J. Natl. Cancer. Inst.
84,
165-174[Abstract/Free Full Text]
|
| 38.
|
Schussler, M. H.,
Skoudy, A.,
Ramaekers, F.,
and Real, F. X.
(1992)
Am. J. Pathol.
140,
559-568[Abstract]
|
| 39.
|
Trask, D. K.,
Band, V.,
Zajchowski, D. A.,
Yaswen, P.,
Suh, T.,
and Sager, R.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2319-2323[Abstract/Free Full Text]
|
| 40.
|
Baribault, H.,
Penner, J.,
Iozzo, R. V.,
and Wilson-Heiner, M.
(1994)
Genes Dev.
8,
2964-2973[Abstract/Free Full Text]
|
| 41.
|
Zarbo, R. J.,
Gown, A. M.,
Nagle, R. B.,
Visscher, D. W.,
and Crissman, J. D.
(1990)
Mod. Pathol.
3,
494-501[Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Alpatov, Y. Shi, G. C. Munguba, B. Moghimi, J.-H. Joo, J. Bungert, and S. P. Sugrue
Corepressor CtBP and Nuclear Speckle Protein Pnn/DRS Differentially Modulate Transcription and Splicing of the E-Cadherin Gene
Mol. Cell. Biol.,
March 1, 2008;
28(5):
1584 - 1595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Alpatov, G. C. Munguba, P. Caton, J. H. Joo, Y. Shi, Y. Shi, M. E. Hunt, and S. P. Sugrue
Nuclear Speckle-Associated Protein Pnn/DRS Binds to the Transcriptional Corepressor CtBP and Relieves CtBP- Mediated Repression of the E-Cadherin Gene
Mol. Cell. Biol.,
December 1, 2004;
24(23):
10223 - 10235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Rieger and G. Chu
Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells
Nucleic Acids Res.,
September 8, 2004;
32(16):
4786 - 4803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Zimowska, J. Shi, G. Munguba, M. R. Jackson, R. Alpatov, M. N. Simmons, Y. Shi, and S. P. Sugrue
Pinin/DRS/memA Interacts with SRp75, SRm300 and SRrp130 in Corneal Epithelial Cells
Invest. Ophthalmol. Vis. Sci.,
November 1, 2003;
44(11):
4715 - 4723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Kedar, S.-J. Kim, A. Robertson, E. Hou, R. Prasad, J. K. Horton, and S. H. Wilson
Direct Interaction between Mammalian DNA Polymerase beta and Proliferating Cell Nuclear Antigen
J. Biol. Chem.,
August 16, 2002;
277(34):
31115 - 31123.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|